Surendra Shah
Hematology & Oncology · Allentown, PANPI 1104829928
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,117 of the $2,451 with a category attached, or 86.4%. 26 manufacturers reported payments, led by AstraZeneca at 24.7% of the total. Reporting peaked in 2019 at $1,988 and has fallen 97.0% since, to $60 in 2021.
Across 93 payments — averaging $26.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$606
- Astellas Pharma US Inc$418
- Genentech USA, Inc.$281
- Johnson & Johnson$178
- Novartis$109
- E.r. Squibb & Sons, L.L.C.$94
- plus $765 from 20 others
What the payments were for
- Food & beverage$2,11786%
- Education$33414%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $606 |
| Astellas Pharma US Inc | 8 | $418 |
| Genentech USA, Inc. | 12 | $281 |
| Johnson & Johnson | 5 | $178 |
| Novartis | 5 | $109 |
| E.r. Squibb & Sons, L.L.C. | 5 | $94 |
| Merck | 6 | $87 |
| Pfizer | 5 | $68 |
| Sanofi | 4 | $63 |
| Foundation Medicine, Inc. | 1 | $58 |
| Eisai Inc. | 3 | $57 |
| Rigel Pharmaceuticals, Inc. | 2 | $49 |
| Seagen Inc. | 3 | $40 |
| Bayer | 2 | $39 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $37 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Amgen | 2 | $33 |
| Incyte Corporation | 2 | $31 |
| Gilead | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Bristol Myers Squibb | 1 | $24 |
| Exelixis Inc. | 2 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,451 in reported general payments places this provider in the 55th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Allentown
- Usama GergisAllentown$1.2M
- Salman FazalPittsburgh$2.3M
- Cyrus KhanPittsburgh$1.9M
- Kit LuHarrisburg$810K
- Henry FungPhiladelphia$730K
- Alexander BarsoukPittsburgh$674K
- Abdalla SholiWilliamsport$576K
- Charu AggarwalPhiladelphia$541K
- Tracey EvansEast Norriton$500K
- Corey LangerPhiladelphia$492K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.